ZetrOZ innovations are consistently recognized both within and outside of the biomedical engineering community.
The National Institutes of Health and the National Institute of Minority Health and Health Disparities awards ZetrOZ Systems a Phase II SBIR grant to develop the next generation of sam® technology to treat patients with arthritis and slow the progression of the disease to reduce the need for surgery. Phase I research results concluded that sam® was successful in treating arthritis pain without the need for other pain management approaches including medication.
The United States Army Medical Material Agency (USAMMA) has awarded ZetrOZ Systems in collaboration with the University of Miami a Phase II contract to develop the next generation of sam® technology to accelerate the healing of soft tissue injuries. Phase I results have demonstrated that sam® accelerates the healing of soft tissue injuries by over 50% compared with standard of care.
The Medical Design Excellence Award (MDEA) is the MedTech Industry’s premier award program. ZetrOZ received the Bronze award for its sam® device.
Governor Malloy congratulated ZetrOZ as a recipient of the Small Business Innovation Research Award and the Small Business Technology Transfer Award.
Senator Blumenthal and the Honorable Jim Himes recognized the company as a recipient of a Federal Industry Leveraging Award at the SBIR/STTR Awards Breakfast for their “innovative work to further technology, research, development and commercialization.” ZetrOZ is a recipient of the National Space Biomedical Research Institute (NSBRI) Award and the 2013 SBIR/STTR Grant.
Medica is the world’s largest medical trade fair, and CompaMed is the leading international trade fair for medtech suppliers. sam® placed second in the “Top 10” list of best innovations at these trade shows held in Dusseldorf, as ranked by Medical Design Technology Magazine.
The Biomedical Engineering Alliance and Consortium (BEACON) is dedicated to the development and commercialization of new medical technology. At its 2014 annual meeting, BEACON gave its Medical Technology Award to ZetrOZ for developing the world’s only multi-hour wearable device, sam®, for pain relief and accelerated healing cleared by the FDA and CE marked.
The Innovation Summit is one of six signature events run by the Connecticut Technology Council each year. From among nearly 100 tech companies to watch, ZetrOZ was named the Most Promising New Technology Product Company of the Year, as well as a 2014 Tech Company to Watch.
The Medical Design Excellence Award (MDEA) is the MedTech Industry’s premier award program. ZetrOZ was a finalist for this award for the UltrOZ Elite wearable ultrasonic therapy system, the company’s therapeutic for horses.
The Empact awards recognize companies in the United States started by entrepreneurs who are age 35 and under and which have annual revenues or operating budgets (for nonprofits) of more than $100,000. Additional factors such as number of employees, social impact, growth over the prior year, and innovativeness, are also taken into account. This award was presented to ZetrOZ at a White House ceremony in 2012.
The New York Creative Core® Emerging Business Competition is the largest privately funded competition of its type in the nation. From a pool of more than 100 applicants, five finalists from the upstate NY region were chosen to pitch their technologies to a judging panel of five venture capitalists from around the country. ZetrOZ was awarded a $50,000 award based on their distinct value proposition and the ability to impact millions of lives worldwide.
The Yet2Step Award honors and encourages innovative technology start-ups by providing them with marketing assistance, introductions to potential commercial partners, and opportunities to present to top industry executives. ZetrOZ was selected as a Top Finalist in this competition.